432 related articles for article (PubMed ID: 10290754)
21. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.
Cook AA; Sanchez ML
Hosp Pharm; 1992 Oct; 27(10):867-9, 872-4, 882. PubMed ID: 10121423
[TBL] [Abstract][Full Text] [Related]
22. How to use structured decision making in developing therapeutic, cost-effective formulary systems.
Crane VS
Hosp Formul; 1993 Oct; 28(10):859-62, 865-7. PubMed ID: 10129135
[TBL] [Abstract][Full Text] [Related]
23. P & T Committee role in advocating rational therapeutics.
Borreson R
Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
[TBL] [Abstract][Full Text] [Related]
24. P & T Committee formulary requests: criteria for admission.
Weintraub M; Guttmacher L
Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315
[TBL] [Abstract][Full Text] [Related]
25. Tri-hospital formulary management: a joint effort to standardize therapy and reduce costs.
Kile DM; McGrath ME; Schindel LP
Hosp Formul; 1987 Feb; 22(2):176, 178, 181. PubMed ID: 10280289
[TBL] [Abstract][Full Text] [Related]
26. Formulary management to reduce cost: P & T committee strategies.
Roberts MJ; Summerfield MR
Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
[TBL] [Abstract][Full Text] [Related]
27. Developing an effective P & T Committee, Part 2.
Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
[TBL] [Abstract][Full Text] [Related]
28. P&T committee: an approach to formulary consideration of antimicrobial agents--introduction.
Andriole VT; Ryan JL
Hosp Formul; 1981 Jun; 16(6):619, 623. PubMed ID: 10251442
[No Abstract] [Full Text] [Related]
29. A survey of selective administration procedures in formulary maintenance.
Quigley MA; Brown WM
Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
[TBL] [Abstract][Full Text] [Related]
30. Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.
Skaer TL
Hosp Formul; 1993 Jun; 28(6):577-84. PubMed ID: 10126586
[TBL] [Abstract][Full Text] [Related]
31. What process does your P&T Committee use to obtain staff physicians' input regarding formulary decisions?
Tompkins GC
Hosp Formul; 1992 Feb; 27(2):197. PubMed ID: 10116717
[No Abstract] [Full Text] [Related]
32. Development and implementation of a comprehensive, criteria-based drug-use review program.
Todd MW; Keith TD; Foster MT
Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
[TBL] [Abstract][Full Text] [Related]
33. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
Summers KH; Szeinbach SL
Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
[TBL] [Abstract][Full Text] [Related]
34. How to develop a proactive formulary system.
Crane VS; Gonzalez ER; Hull BL
Hosp Formul; 1994 Oct; 29(10):700-2, 704-8, 710. PubMed ID: 10137847
[TBL] [Abstract][Full Text] [Related]
35. Strategic planning for the management of biotechnologic products: development of a biotech committee.
Akinwande K; Tse T; Darab M; Madura A; Cerceo R; Al-Hani A
Hosp Formul; 1993 Sep; 28(9):773-4, 777-80. PubMed ID: 10128393
[TBL] [Abstract][Full Text] [Related]
36. An approach to cost-effective antibiotic utilization.
Venezio FR; Waitley DW
Hosp Formul; 1988 Dec; 23 Suppl D():32-5. PubMed ID: 10312796
[TBL] [Abstract][Full Text] [Related]
37. Cephalosporin selection: view from a beleaguered P & T committee member.
Talley JH
Hosp Formul; 1986 Jan; 21(1):76-8, 83-4. PubMed ID: 10275082
[TBL] [Abstract][Full Text] [Related]
38. Survey of formulary system policies and procedures.
Rascati KL
Am J Hosp Pharm; 1992 Jan; 49(1):100-3. PubMed ID: 1570847
[TBL] [Abstract][Full Text] [Related]
39. Cost containment through P & T committee drug utilization review.
Bender FH; DeMatteo CS
Hosp Formul; 1984 Aug; 19(8):699-700, 705-7. PubMed ID: 10267391
[TBL] [Abstract][Full Text] [Related]
40. Strategies for deleting popular drugs from a hospital formulary.
Lemay AP; Salzer LB; Visconti JA; Latiolais CJ
Am J Hosp Pharm; 1981 Apr; 38(4):506-10. PubMed ID: 7282675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
